Pilot Study of an mHealth Intervention for Living Donor Follow-up
Running, not enrolling · Not applicable
Conditions studied: Living Donors, Nephrectomy, Kidney
In brief
The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of follow-up compliance among living kidney donors. The investigators aim to test this by randomly assigning living kidney donors to the intervention (use of mHealth application to complete required living kidney donor follow-up at 6 months, 1 year, and 2 years) or control arm (standard of care) upon discharge from their initial donation hospitalization, and tracking follow-up compliance over time. The study population will be approximately 400 living kidney donors who undergo donor nephrectomy at Methodist Specialty and Transplant Hospital (200/year for 2 years). The investigators will also recruit patients from the Vanderbilt University Medical Center into the study, however, these study participants are not a part of the Pilot Randomized Clinical Trial (RCT).
Key facts
- Study ID
- NCT03400085
- Run by
- Johns Hopkins University
- People needed
- 400
- Starts
- 2018-05-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-12-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults (≥18 years)
- Have undergone live donor nephrectomy at Methodist Specialty and Transplant Hospital in San Antonio, Texas
- Have undergone live donor nephrectomy at Vanderbilt University Medical Center in Nashville, Tennessee
You may not qualify if…
- Participants will only be excluded if they do not consent to the study
Where it is running
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
- Methodist Specialty and Transplant Hospital — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.